The similar efficacy and safety of lenograstim and filgrastim biosimilar for Japanese with primary non-Hodgkin-lymphoma

被引:0
|
作者
Tanimoto, Kazuki [1 ]
Sakamoto, Keiji [1 ]
机构
[1] Fukuoka Red Cross Hosp, Japanese Red Cross Soc, Dept Hematol & Oncol, Fukuoka, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1-6-52
引用
收藏
页码:117 / 117
页数:1
相关论文
共 50 条
  • [41] NON-HODGKIN-LYMPHOMA IN HEART/LUNG TRANSPLANT RECIPIENTS
    EGAN, J
    STEWART, J
    YONAN, N
    ARRAND, J
    WOODCOCK, A
    LANCET, 1994, 343 (8895): : 481 - 481
  • [42] RITUXIMAB FOR NON HODGKIN LYMPHOMA: OVERVIEW OF EFFICACY AND SAFETY
    Costa, J. O.
    Lemos, L. L. P.
    Junior, A. A. G.
    Acurcio, F. A.
    VALUE IN HEALTH, 2013, 16 (03) : A128 - A128
  • [43] SECONDARY INVOLVEMENT OF THE BREAST IN CASES OF NON-HODGKIN-LYMPHOMA
    GROBE, N
    BALSCHAT, S
    GRAU, I
    LANGE, H
    ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM, 1991, 46 (09): : 649 - 651
  • [44] CLASSIFICATION DIAGNOSTICS AND PROGNOSIS OF MALIGNANG NON-HODGKIN-LYMPHOMA
    RUDIGER, KD
    WUTKE, K
    DRESCHER, W
    ANGER, G
    WOCKEL, W
    DEUTSCHE GESUNDHEITSWESEN-ZEITSCHRIFT FUR KLINISCHE MEDIZIN, 1978, 33 (17): : 783 - 787
  • [45] Intraocular manifestation as initial symptoms of a Non-Hodgkin-Lymphoma
    Werschnik, C
    Lommatzsch, PK
    Rockel, A
    Steinert, A
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2000, 216 (03) : 181 - 183
  • [46] MOLECULAR PATHOGENESIS OF NON-HODGKIN-LYMPHOMA - A CLINICAL PERSPECTIVE
    GAIDANO, G
    PASTORE, C
    VOLPE, G
    HAEMATOLOGICA, 1995, 80 (05) : 454 - 472
  • [47] RESULTS OF A DIAGNOSTIC AND THERAPEUTIC STUDY IN NON-HODGKIN-LYMPHOMA
    JANDL, H
    FRANKE, A
    KAMMERER, R
    SPORMANN, H
    MACHURA, R
    DEUTSCHE GESUNDHEITSWESEN-ZEITSCHRIFT FUR KLINISCHE MEDIZIN, 1984, 39 (19): : 731 - 735
  • [48] CYTOGENETIC ABNORMALITIES IN THE LEUKEMIC PHASE OF NON-HODGKIN-LYMPHOMA
    KHOKHAR, MT
    BRITOBABAPULLE, V
    MATUTES, E
    CATOVSKY, D
    CANCER GENETICS AND CYTOGENETICS, 1995, 83 (01) : 18 - 24
  • [49] The evaluation of the efficacy and safety of original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) in CD34+peripheral hematopoietic stem cell mobilisation procedures for alloHSCT donors
    Sivgin, S.
    Karakus, E.
    Keklik, M.
    Zararsiz, G.
    Solmaz, M.
    Kaynar, L.
    Eser, B.
    Unal, A.
    Cetin, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S367 - S367
  • [50] Efficacy and safety of biosimilar rituximab (Zytux™) in newly diagnosed patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia
    Alwan, Alaa Fadhil
    Abdulsahib, Manal Ali
    Abbas, Duaa Dhahir
    Abdulsattar, Saraa Ali
    Ensaif, Reem Talib
    HEMATOLOGY REPORTS, 2020, 12 (03) : 46 - 50